Literature DB >> 32651483

Targeting DNA repair defects in prostate cancer.

Clemens Thoma1.   

Abstract

Entities:  

Mesh：

Year:  2020        PMID： 32651483     DOI： 10.1038/s41585-020-0360-6

Source DB:  PubMed          Journal:  Nat Rev Urol        ISSN： 1759-4812            Impact factor:   14.432


× No keyword cloud information.
  1 in total

1.  Olaparib for DNA repair-deficient prostate cancer - one for all, or all for one?

Authors:  Emmanuel S Antonarakis
Journal:  Nat Rev Clin Oncol       Date:  2020-08       Impact factor: 66.675
  1 in total
  2 in total

1.  BRCA2 Alterations in Neuroendocrine/Small-Cell Carcinoma Prostate Cancer: A Case Series.

Authors:  Lynn Symonds; Erik Konnick; Funda Vakar-Lopez; Heather H Cheng; Michael T Schweizer; Peter S Nelson; Colin C Pritchard; Bruce Montgomery
Journal:  JCO Precis Oncol       Date:  2022-07

2.  Overexpression of claspin promotes docetaxel resistance and is associated with prostate-specific antigen recurrence in prostate cancer.

Authors:  Takashi Babasaki; Kazuhiro Sentani; Yohei Sekino; Go Kobayashi; Quoc Thang Pham; Narutaka Katsuya; Shintaro Akabane; Daiki Taniyama; Tetsutaro Hayashi; Masaki Shiota; Naohide Oue; Jun Teishima; Akio Matsubara; Wataru Yasui
Journal:  Cancer Med       Date:  2021-07-09       Impact factor: 4.452
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.